These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 1374102)

  • 1. Prostaglandin E2 and other cyclic AMP-elevating agents modulate IL-2 and IL-2R alpha gene expression at multiple levels.
    Anastassiou ED; Paliogianni F; Balow JP; Yamada H; Boumpas DT
    J Immunol; 1992 May; 148(9):2845-52. PubMed ID: 1374102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delineation of the mechanism of inhibition of human T cell activation by PGE2.
    Minakuchi R; Wacholtz MC; Davis LS; Lipsky PE
    J Immunol; 1990 Oct; 145(8):2616-25. PubMed ID: 1976699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E2 and the increase of intracellular cAMP inhibit the expression of interleukin 2 receptors in human T cells.
    Rincón M; Tugores A; López-Rivas A; Silva A; Alonso M; De Landázuri MO; López-Botet M
    Eur J Immunol; 1988 Nov; 18(11):1791-6. PubMed ID: 2849551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic AMP synergy with Ca2+ for production of IFN-gamma by a cytolytic T cell clone is post-transcriptional.
    Kaldy P; Schmitt-Verhulst AM
    J Immunol; 1991 Apr; 146(7):2382-7. PubMed ID: 1848581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Chinese herbal remedy, T2, inhibits mitogen-induced cytokine gene transcription by T cells, but not initial signal transduction.
    Tao X; Davis LS; Hashimoto K; Lipsky PE
    J Pharmacol Exp Ther; 1996 Jan; 276(1):316-25. PubMed ID: 8558449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of anti-proliferative cyclic AMP on interleukin 2-stimulated gene expression.
    Farrar WL; Evans SW; Rapp UR; Cleveland JL
    J Immunol; 1987 Sep; 139(6):2075-80. PubMed ID: 3040863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of murine T cell activation by cholera toxin B subunit is not mediated through the phosphatidylinositol second messenger system.
    Woogen SD; Turo K; Dieleman LA; Beagley KW; Elson CO
    J Immunol; 1993 Apr; 150(8 Pt 1):3274-83. PubMed ID: 8468469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin E2 acts at two distinct pathways of T lymphocyte activation: inhibition of interleukin 2 production and down-regulation of transferrin receptor expression.
    Chouaib S; Welte K; Mertelsmann R; Dupont B
    J Immunol; 1985 Aug; 135(2):1172-9. PubMed ID: 2989362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of transforming growth factor-beta on early and late activation events in human T cells.
    Ahuja SS; Paliogianni F; Yamada H; Balow JE; Boumpas DT
    J Immunol; 1993 Apr; 150(8 Pt 1):3109-18. PubMed ID: 8468460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexamethasone inhibits human interleukin 2 but not interleukin 2 receptor gene expression in vitro at the level of nuclear transcription.
    Boumpas DT; Anastassiou ED; Older SA; Tsokos GC; Nelson DL; Balow JE
    J Clin Invest; 1991 May; 87(5):1739-47. PubMed ID: 2022743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of hepatocyte growth factor is up-regulated through activation of a cAMP-mediated pathway.
    Matsunaga T; Gohda E; Takebe T; Wu YL; Iwao M; Kataoka H; Yamamoto I
    Exp Cell Res; 1994 Feb; 210(2):326-35. PubMed ID: 7507855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholera toxin inhibits resting human T cell activation via a cAMP-independent pathway.
    Anderson DL; Tsoukas CD
    J Immunol; 1989 Dec; 143(11):3647-52. PubMed ID: 2555413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costimulatory signals modulate the antiproliferative effects of agents that elevate cAMP in T cells.
    Bartik MM; Bauman GP; Brooks WH; Roszman TL
    Cell Immunol; 1994 Oct; 158(1):116-30. PubMed ID: 8087859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PGE2 induces IL-1beta gene expression in mouse osteoblasts through a cAMP-PKA signaling pathway.
    Park YG; Kang SK; Noh SH; Park KK; Chang YC; Lee YC; Kim CH
    Int Immunopharmacol; 2004 Jun; 4(6):779-89. PubMed ID: 15135319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevation of 3'5' cyclic adenosine monophosphate alters CD3 and CD25 antigens expression in activated T lymphocytes.
    Iwaz J; Lafont S; Cordier G; Revillard JP
    J Clin Lab Immunol; 1989 Jun; 29(2):85-9. PubMed ID: 2561159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two differential effects of cyclic adenosine 3',5'-monophosphate on IL-5 production by antigen-specific human T cell line.
    Kaminuma O; Mori A; Ogawa K; Wada K; Kikkawa H; Naito K; Suko M; Okudaira H
    J Pharmacol Exp Ther; 1997 Oct; 283(1):345-9. PubMed ID: 9336342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte-macrophage colony-stimulating factor expression is regulated at transcriptional and posttranscriptional levels in a murine bone marrow stromal cell line.
    Derigs HG; Reifel-Miller A; Kaushansky K; Hromas RA; Boswell HS
    Exp Hematol; 1994 Aug; 22(9):924-32. PubMed ID: 8062890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early immune response and regulation of IL-2 receptor subunits.
    Hughes-Fulford M; Sugano E; Schopper T; Li CF; Boonyaratanakornkit JB; Cogoli A
    Cell Signal; 2005 Sep; 17(9):1111-24. PubMed ID: 15993752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-alpha generation from human peripheral blood monocytes.
    Seldon PM; Barnes PJ; Giembycz MA
    Cell Biochem Biophys; 1998; 29(1-2):179-201. PubMed ID: 9631245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus-infected adherent cell-derived inhibitory factor (p29) inhibits normal T cell proliferation through decreased expression of high affinity interleukin-2 receptors and production of interleukin-2.
    Ammar A; Sahraoui Y; Tsapis A; Bertoli AM; Jasmin C; Georgoulias V
    J Clin Invest; 1992 Jul; 90(1):8-14. PubMed ID: 1321845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.